Inhibition of DNA Repair in Combination with Temozolomide or Dianhydrogalactiol Overcomes Temozolomide-Resistant Glioma Cells

SIMPLE SUMMARY: Glioblastoma is the most prevalent and lethal brain tumor. Temozolomide is usually used for the treatment of glioblastoma. The poor prognosis of the tumor is due to drug resistance and tumor heterogeneity. The mechanism of the resistance to temozolomide is various within the same tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohba, Shigeo, Yamashiro, Kei, Hirose, Yuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197190/
https://www.ncbi.nlm.nih.gov/pubmed/34073837
http://dx.doi.org/10.3390/cancers13112570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197190/
https://www.ncbi.nlm.nih.gov/pubmed/34073837
http://dx.doi.org/10.3390/cancers13112570

Ejemplares similares